GB0819113D0 - An antibody - Google Patents

An antibody

Info

Publication number
GB0819113D0
GB0819113D0 GB0819113A GB0819113A GB0819113D0 GB 0819113 D0 GB0819113 D0 GB 0819113D0 GB 0819113 A GB0819113 A GB 0819113A GB 0819113 A GB0819113 A GB 0819113A GB 0819113 D0 GB0819113 D0 GB 0819113D0
Authority
GB
United Kingdom
Prior art keywords
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0819113A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neutec Pharma Ltd
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Priority to GB0819113A priority Critical patent/GB0819113D0/en
Publication of GB0819113D0 publication Critical patent/GB0819113D0/en
Ceased legal-status Critical Current

Links

GB0819113A 2008-10-17 2008-10-17 An antibody Ceased GB0819113D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0819113A GB0819113D0 (en) 2008-10-17 2008-10-17 An antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0819113A GB0819113D0 (en) 2008-10-17 2008-10-17 An antibody

Publications (1)

Publication Number Publication Date
GB0819113D0 true GB0819113D0 (en) 2008-11-26

Family

ID=40097637

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0819113A Ceased GB0819113D0 (en) 2008-10-17 2008-10-17 An antibody

Country Status (1)

Country Link
GB (1) GB0819113D0 (en)

Similar Documents

Publication Publication Date Title
IL276622A (en) Antibody formulation
EP2241578A4 (en) Anti-cldn6 antibody
ZA201102119B (en) Improved antibody libraies
GB0821100D0 (en) Antibodies
GB0708002D0 (en) Antibodies
ZA201104545B (en) Anti-siglec-15 antibody
HK1136970A1 (en) Penta-specific antibody
IL210903A0 (en) Anit-il-12/il-23 antibodies
EP2358392A4 (en) Antibody formulation
EP2138576A4 (en) Anti-claudin-4 antibody
EP2337798A4 (en) Bsa-specific antibodies
EP2172483A4 (en) ANTI-Muc17 ANTIBODY
IL205073A0 (en) Anti-bst2 antibody
ZA201006099B (en) Anti-tyrp1 antibodies
GB0718737D0 (en) Antibodies
HK1170745A1 (en) Antibodies against il-17br il-17br
ZA201007976B (en) Anti-pirb antibodies
GB0818356D0 (en) Antibodies
GB2473934B (en) Anti-VEEV antibody
GB0911770D0 (en) Antibody
EP2264071A4 (en) Antibody having an immune-enhancement function
GB0819113D0 (en) An antibody
GB0817622D0 (en) Antibody
GB0817621D0 (en) Antibody
GB0823562D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)